Who Owns Organogenesis Stock?
NASDAQ: ORGOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 51.92%
- Held by insiders
- 44.17%
- Institutional holders
- 165
- Institutions 51.9%
- Insiders 44.2%
- Public and other 3.9%
Who owns Organogenesis stock?
Institutional investors own about 51.9% of Organogenesis's shares, spread across 165 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 44.17% of ORGO.
The largest institutional holders are Morgan Stanley (9.08%), Soleus Capital Management, L.P. (8.71%) and Blackrock Inc. (5.96%). Together, the top 10 institutions control 36.9% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their ORGO positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ORGO
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Morgan Stanley | 11.78M | 9.08% | +0.5% |
| Soleus Capital Management, L.P. | 11.30M | 8.71% | +11.4% |
| Blackrock Inc. | 7.74M | 5.96% | +6.8% |
| Shaw D.E. & Co., Inc. | 3.13M | 2.41% | +8.4% |
| Vanguard Capital Management LLC | 2.95M | 2.27% | +1.4% |
| AQR Capital Management, LLC | 2.84M | 2.19% | -5.8% |
| Dimensional Fund Advisors LP | 2.45M | 1.89% | -19.7% |
| Acadian Asset Management. LLC | 1.97M | 1.52% | +27.8% |
| Assenagon Asset Management S.A. | 1.95M | 1.51% | -0.7% |
| Geode Capital Management, LLC | 1.84M | 1.41% | -5.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ORGO
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.99M | 1.53% |
| iShares Trust-iShares Russell 2000 ETF | 1.81M | 1.40% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 842.14K | 0.65% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 654.82K | 0.50% |
| iShares Trust-iShares Russell 2000 Value ETF | 632.07K | 0.49% |
| Vanguard Explorer Fund | 492.50K | 0.38% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 395.25K | 0.30% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 356.71K | 0.27% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Targeted Value Portfolio | 356.42K | 0.27% |
| SCHWAB STRATEGIC TRUST-Schwab U.S. Small-Cap ETF | 347.53K | 0.27% |
Frequently asked questions
Who is the largest shareholder of Organogenesis?
Morgan Stanley is the largest institutional shareholder of ORGO, owning 9.08% of shares outstanding (11.78M shares) as of its latest 13F filing.
What percentage of Organogenesis is owned by institutions?
Institutions own about 51.9% of ORGO shares and 93.0% of the public float.
How much of Organogenesis do insiders own?
Insiders, such as officers and directors, own about 44.17% of ORGO shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.